Agnes Halbauer Nee Nagy

Title: Agnes Halbauer Nee Nagy: Innovator in Pharmaceutical Chemistry

Introduction

Agnes Halbauer Nee Nagy is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of valuable compounds. Her work has implications for the medical industry, especially in the area of blood platelet antiaggregative agents.

Latest Patents

Agnes holds a patent for a process related to the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2[3H]-one, commonly known as anagrelide. This compound is recognized for its effectiveness as a blood platelet antiaggregative agent. The patented process involves the thermal cyclization of a new 2-cyanoiminoquinazoline derivative in an acidic medium, which allows for the industrial-scale production of anagrelide while overcoming the limitations of previous methods.

Career Highlights

Agnes is associated with Egis Gyogyszergyar, a prominent pharmaceutical company in Hungary. Her work at the company has been instrumental in advancing the production techniques for important pharmaceutical compounds. She has demonstrated a commitment to innovation and excellence in her field.

Collaborations

Agnes has collaborated with notable colleagues, including Jozsef Reiter and Peter Trinka. These partnerships have contributed to her success and the advancement of her research in pharmaceutical chemistry.

Conclusion

Agnes Halbauer Nee Nagy is a pioneering inventor whose work in the preparation of pharmaceutical compounds has made a significant impact in the medical field. Her innovative processes and collaborations highlight her dedication to advancing pharmaceutical science.